About: Methoxphenidine

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Methoxphenidine Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FMethoxphenidine&invfp=IFP_OFF&sas=SAME_AS_OFF

Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relatio

Attributes	Values
rdf:type	Thing dul:ChemicalObject chemical substance Drug yago:WikicatNMDAReceptorAntagonists yago:Adversary109773245 yago:CausalAgent100007347 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo drug yago:Whole100003553
rdfs:label	Methoxphenidine (en)
rdfs:comment	Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relatio (en)
foaf:depiction
dcterms:subject	Designer drugs NMDA receptor antagonists Phenol ethers Piperidines Diarylethylamines Dissociative drugs
Wikipage page ID	41255861 (xsd:integer)
Wikipage revision ID	1099858799 (xsd:integer)
Link from a Wikipage to another Wikipage	Designer drug Designer drugs NMDA receptor antagonists Phenol ethers Piperidines Ephenidine Anisole Lefetamine Lorazepam MT-45 Driving under the influence AD-1211 Fluorolintane Diarylethylamines Dissociative drugs Health Canada Lanicemine Diphenidine Dissociative drug Arylcyclohexylamine Phencyclidine Structure–activity relationship NMDA receptor antagonist NMDA receptor
sameAs	Methoxphenidine Methoxphenidine Methoxphenidine Methoxphenidine Methoxphenidine
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Hallucinogens dbt:Ionotropic_glutamate_receptor_modulators dbt:Reflist dbt:Short_description dbt:Cascite
thumbnail	wiki-commons:Special:FilePath/Methoxphenidine_structure.svg?width=300
c	20 (xsd:integer)
CAS number	127529 (xsd:integer)
ChemSpiderID	52085156 (xsd:integer)
H	25 (xsd:integer)
IUPAC name	-1 (xsd:integer)
legal DE	NpSG (en)
legal status	Illegal in China and Sweden (en)
legal UK	PSA (en)
n	1 (xsd:integer)
O	1 (xsd:integer)
PubChem	67833251 (xsd:integer)
routes of administration	Oral, Rectal (en)
SMILES	COC1=CCN3CCCCC3 (en)
StdInChI	1 (xsd:integer)
StdInChIKey	QXXCUXIRBHSITD-UHFFFAOYSA-N (en)
UNII	H2W7A6GZGX (en)
has abstract	Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. Methoxphenidine was first reported in a 1989 patent where it was tested as a treatment for neurotoxic injury. Shortly after the 2013 UK ban on arylcyclohexylamines methoxphenidine and the related compound diphenidine became available on the gray market, where it has been encountered as a powder and in tablet form. Though diphenidine possesses higher affinity for the NMDA receptor, anecdotal reports suggest methoxphenidine has greater oral potency. Of the three isomeric anisyl-substituents methoxphenidine has affinity for the NMDA receptor that is higher than 4-MeO-Diphenidine but lower than 3-MeO-Diphenidine, a structure–activity relationship shared by the arylcyclohexylamines. (en)
legal CA	Schedule I (en)
prov:wasDerivedFrom	wikipedia-en:Methoxphenidine?oldid=1099858799&ns=0
page length (characters) of wiki page	10107 (xsd:nonNegativeInteger)
CAS number	127529-46-8
FDA UNII code	H2W7A6GZGX
PubChem	67833251
foaf:isPrimaryTopicOf	wikipedia-en:Methoxphenidine
is Link from a Wikipage to another Wikipage of	List of designer drugs Delucemine Remacemide UWA-001 Ephenidine N-Methyl-D-aspartic acid NPDPA Controlled Drugs and Substances Act Lefetamine MT-45 Budipine AD-1211 Fluorolintane

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 59 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software